KEGG   PATHWAY: hmh04310
Entry
hmh04310                    Pathway                                
Name
Wnt signaling pathway - Hylobates moloch (silvery gibbon)
Description
Wnt proteins are secreted morphogens that are required for basic developmental processes, such as cell-fate specification, progenitor-cell proliferation and the control of asymmetric cell division, in many different species and organs. There are at least three different Wnt pathways: the canonical pathway, the planar cell polarity (PCP) pathway and the Wnt/Ca2+ pathway. In the canonical Wnt pathway, the major effect of Wnt ligand binding to its receptor is the stabilization of cytoplasmic beta-catenin through inhibition of the bea-catenin degradation complex. Beta-catenin is then free to enter the nucleus and activate Wnt-regulated genes through its interaction with TCF (T-cell factor) family transcription factors and concomitant recruitment of coactivators. Planar cell polarity (PCP) signaling leads to the activation of the small GTPases RHOA (RAS homologue gene-family member A) and RAC1, which activate the stress kinase JNK (Jun N-terminal kinase) and ROCK (RHO-associated coiled-coil-containing protein kinase 1) and leads to remodelling of the cytoskeleton and changes in cell adhesion and motility. WNT-Ca2+ signalling is mediated through G proteins and phospholipases and leads to transient increases in cytoplasmic free calcium that subsequently activate the kinase PKC (protein kinase C) and CAMKII (calcium calmodulin mediated kinase II) and the phosphatase calcineurin.
Class
Environmental Information Processing; Signal transduction
Pathway map
hmh04310  Wnt signaling pathway
hmh04310

Other DBs
GO: 0016055
Organism
Hylobates moloch (silvery gibbon) [GN:hmh]
Gene
116456254  SFRP5; secreted frizzled-related protein 5 [KO:K02222]
116456610  FRAT2; GSK-3-binding protein FRAT2 [KO:K03096]
116456615  FRAT1; proto-oncogene FRAT1 [KO:K03069]
116456830  CTBP1; C-terminal-binding protein 1 isoform X1 [KO:K04496] [EC:1.1.1.428]
116456957  NKD2; protein naked cuticle homolog 2 isoform X1 [KO:K03213]
116457023  CTNND2; catenin delta-2 isoform X1 [KO:K23491]
116457363  JUN; transcription factor Jun [KO:K04448]
116457566  ROR1; inactive tyrosine-protein kinase transmembrane receptor ROR1 isoform X1 [KO:K05122] [EC:2.7.10.1]
116457618  LGR6; leucine-rich repeat-containing G-protein coupled receptor 6 isoform X1 [KO:K08399]
116458060  DKK1; dickkopf-related protein 1 [KO:K02165]
116458095  WNT3A; protein Wnt-3a [KO:K00312]
116458096  WNT9A; protein Wnt-9a [KO:K01064]
116458301  EP300; histone acetyltransferase p300 [KO:K04498] [EC:2.3.1.48]
116458418  PRKACG; LOW QUALITY PROTEIN: cAMP-dependent protein kinase catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]
116458544  RBX1; E3 ubiquitin-protein ligase RBX1 [KO:K03868] [EC:2.3.2.32]
116458566  RAC2; ras-related C3 botulinum toxin substrate 2 [KO:K07860]
116458587  SIRT1; NAD-dependent protein deacetylase sirtuin-1 isoform X1 [KO:K11411] [EC:2.3.1.286]
116458589  CER1; cerberus [KO:K01645]
116458901  SERPINF1; pigment epithelium-derived factor [KO:K19614]
116458970  WNT7B; protein Wnt-7b [KO:K00572]
116459052  TP53; cellular tumor antigen p53 [KO:K04451]
116459316  DVL2; segment polarity protein dishevelled homolog DVL-2 isoform X1 [KO:K02353]
116459388  CSNK1E; casein kinase I isoform X1 [KO:K08960] [EC:2.7.11.1]
116459398  CBY1; protein chibby homolog 1 isoform X4 [KO:K23402]
116459459  ZNRF3; E3 ubiquitin-protein ligase ZNRF3 isoform X1 [KO:K16273] [EC:2.3.2.27]
116459475  PPP3CB; serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
116459674  DAAM2; disheveled-associated activator of morphogenesis 2 isoform X1 [KO:K04512]
116459675  CAMK2G; calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X1 [KO:K04515] [EC:2.7.11.17]
116459823  PPARD; peroxisome proliferator-activated receptor delta [KO:K04504]
116460128  PRICKLE4; prickle-like protein 4 [KO:K04511]
116460133  CCND3; G1/S-specific cyclin-D3 isoform X1 [KO:K10152]
116460270  CSNK2B; casein kinase II subunit beta isoform X2 [KO:K03115]
116460769  MAPK8; mitogen-activated protein kinase 8 isoform X1 [KO:K04440] [EC:2.7.11.24]
116461045  NFATC2; nuclear factor of activated T-cells, cytoplasmic 2 isoform X1 [KO:K17332]
116461175  CSNK2A1; casein kinase II subunit alpha [KO:K03097] [EC:2.7.11.1]
116461202  PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X1 [KO:K05858] [EC:3.1.4.11]
116461348  RSPO4; R-spondin-4 [KO:K23099]
116461370  PLCB1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 isoform X2 [KO:K05858] [EC:3.1.4.11]
116461715  RYK; tyrosine-protein kinase RYK isoform X1 [KO:K05128] [EC:2.7.10.1]
116461764  FZD3; frizzled-3 [KO:K02329]
116461820  SFRP1; secreted frizzled-related protein 1 [KO:K02166]
116461832  DKK4; dickkopf-related protein 4 [KO:K02165]
116461844  PPP3CC; serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
116461847  CCAR2; cell cycle and apoptosis regulator protein 2 [KO:K25816]
116462013  WNT10B; protein Wnt-10b [KO:K01357]
116462014  WNT1; proto-oncogene Wnt-1 [KO:K03209]
116462115  BAMBI; BMP and activin membrane-bound inhibitor homolog [KO:K10162]
116462417  AXIN1; axin-1 isoform X1 [KO:K02157]
116462715  CREBBP; CREB-binding protein isoform X1 [KO:K04498] [EC:2.3.1.48]
116463099  CAMK2D; calcium/calmodulin-dependent protein kinase type II subunit delta isoform X2 [KO:K04515] [EC:2.7.11.17]
116463128  MAPK10; mitogen-activated protein kinase 10 isoform X1 [KO:K04440] [EC:2.7.11.24]
116463269  APCDD1L; protein APCDD1-like [KO:K25812]
116463386  [KO:K25812]
116463760  [KO:K04385]
116463765  [KO:K04385]
116465142  [KO:K04508]
116465435  SFRP2; secreted frizzled-related protein 2 [KO:K02176]
116466625  PRICKLE2; prickle-like protein 2 [KO:K04511]
116466764  WNT7A; protein Wnt-7a [KO:K00572]
116466808  RUVBL1; ruvB-like 1 [KO:K04499] [EC:5.6.2.4]
116466895  GSK3B; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
116467072  CSNK1A1L; casein kinase I [KO:K08957] [EC:2.7.11.1]
116468452  NFATC1; nuclear factor of activated T-cells, cytoplasmic 1 isoform X1 [KO:K04446]
116468535  SMAD4; mothers against decapentaplegic homolog 4 [KO:K04501]
116468750  APCDD1; protein APCDD1 [KO:K25812]
116468938  PLCB3; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 [KO:K05858] [EC:3.1.4.11]
116469025  FOSL1; fos-related antigen 1 [KO:K04502]
116469103  LRP5; low-density lipoprotein receptor-related protein 5 [KO:K03068]
116469117  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
116469204  VANGL2; vang-like protein 2 [KO:K04510]
116469279  [KO:K04513]
116469562  VANGL1; vang-like protein 1 [KO:K04510]
116469600  WNT2B; protein Wnt-2b [KO:K00182]
116469793  MAP3K7; mitogen-activated protein kinase kinase kinase 7 isoform X1 [KO:K04427] [EC:2.7.11.25]
116469844  PRKACB; cAMP-dependent protein kinase catalytic subunit beta isoform X1 [KO:K04345] [EC:2.7.11.11]
116470457  TLE7; transducin-like enhancer protein 7 [KO:K04497]
116470472  WNT8A; protein Wnt-8a isoform X1 [KO:K00714]
116470866  [KO:K03347]
116470929  MCC; colorectal mutant cancer protein [KO:K26734]
116470936  APC; adenomatous polyposis coli protein isoform X1 [KO:K02085]
116471147  PRKCB; protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
116471234  SIAH1; E3 ubiquitin-protein ligase SIAH1 isoform X2 [KO:K04506] [EC:2.3.2.27]
116471248  NKD1; protein naked cuticle homolog 1 [KO:K03213]
116471321  CSNK2A2; casein kinase II subunit alpha' [KO:K03097] [EC:2.7.11.1]
116471414  NFATC3; nuclear factor of activated T-cells, cytoplasmic 3 isoform X2 [KO:K17333]
116471505  TCF7; LOW QUALITY PROTEIN: transcription factor 7 [KO:K02620]
116471506  SKP1; S-phase kinase-associated protein 1 [KO:K03094]
116471700  CSNK1A1; casein kinase I isoform X3 [KO:K08957] [EC:2.7.11.1]
116471714  CAMK2A; calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X1 [KO:K04515] [EC:2.7.11.17]
116471826  RSPO3; R-spondin-3 isoform X2 [KO:K23098]
116471847  FBXW11; F-box/WD repeat-containing protein 11 isoform X1 [KO:K03362]
116471970  MAPK9; mitogen-activated protein kinase 9 isoform X1 [KO:K04440] [EC:2.7.11.24]
116472265  RSPO1; R-spondin-1 isoform X1 [KO:K19471]
116472519  WNT5B; protein Wnt-5b [KO:K00444]
116472548  CCND2; G1/S-specific cyclin-D2 [KO:K10151]
116472692  LRP6; low-density lipoprotein receptor-related protein 6 isoform X1 [KO:K03068]
116472739  [KO:K03094]
116473210  CACYBP; calcyclin-binding protein isoform X1 [KO:K04507]
116473363  WNT5A; protein Wnt-5a [KO:K00444]
116473478  RHOA; transforming protein RhoA [KO:K04513]
116473623  CTNNB1; catenin beta-1 isoform X1 [KO:K02105]
116474162  WNT9B; protein Wnt-9b [KO:K01064]
116474164  WNT3; proto-oncogene Wnt-3 [KO:K00312]
116474402  RNF43; E3 ubiquitin-protein ligase RNF43 isoform X2 [KO:K15694] [EC:2.3.2.27]
116474630  NLK; serine/threonine-protein kinase NLK isoform X1 [KO:K04468] [EC:2.7.11.24]
116474915  SOST; sclerostin [KO:K16834]
116474949  FZD2; frizzled-2 [KO:K02235]
116475182  [KO:K04497]
116475184  TLE1; transducin-like enhancer protein 1 isoform X1 [KO:K04497]
116475330  INVS; inversin isoform X1 [KO:K19626]
116475348  PPP3R2; calcineurin subunit B type 2 [KO:K06268]
116475426  ROR2; tyrosine-protein kinase transmembrane receptor ROR2 [KO:K05123] [EC:2.7.10.1]
116476409  LGR4; leucine-rich repeat-containing G-protein coupled receptor 4 isoform X1 [KO:K04309]
116476785  FZD4; frizzled-4 [KO:K02354]
116477384  WNT11; protein Wnt-11 [KO:K01384]
116477414  MMP7; matrilysin [KO:K01397] [EC:3.4.24.23]
116478588  PRKACA; cAMP-dependent protein kinase catalytic subunit alpha isoform X1 [KO:K04345] [EC:2.7.11.11]
116478959  WIF1; wnt inhibitory factor 1 [KO:K01691]
116479013  LGR5; leucine-rich repeat-containing G-protein coupled receptor 5 isoform X1 [KO:K04308]
116479165  PRKCG; protein kinase C gamma type [KO:K19663] [EC:2.7.11.13]
116479176  LEF1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
116479382  FZD10; frizzled-10 [KO:K02842]
116479887  DVL3; segment polarity protein dishevelled homolog DVL-3 [KO:K02353]
116479929  SENP2; sentrin-specific protease 2 [KO:K03345] [EC:3.4.22.68]
116480204  DKK2; dickkopf-related protein 2 [KO:K02165]
116480242  ROCK2; rho-associated protein kinase 2 [KO:K17388] [EC:2.7.11.1]
116480287  [KO:K04392]
116480936  FZD8; frizzled-8 [KO:K02375]
116481077  PRICKLE1; prickle-like protein 1 [KO:K04511]
116481258  TBL1XR1; F-box-like/WD repeat-containing protein TBL1XR1 isoform X1 [KO:K04508]
116481643  TLE3; transducin-like enhancer protein 3 isoform X1 [KO:K04497]
116481756  CXXC4; CXXC-type zinc finger protein 4 [KO:K03344]
116481969  PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X6 [KO:K05858] [EC:3.1.4.11]
116482218  CTBP2; C-terminal-binding protein 2 isoform X1 [KO:K04496] [EC:1.1.1.428]
116482351  SMAD3; mothers against decapentaplegic homolog 3 isoform X2 [KO:K23605]
116483446  TCF7L2; transcription factor 7-like 2 isoform X12 [KO:K04491]
116483520  PPP3R1; calcineurin subunit B type 1 isoform X2 [KO:K06268]
116483590  TCF7L1; transcription factor 7-like 1 isoform X2 [KO:K04490]
116483718  TLE6; transducin-like enhancer protein 6 [KO:K04497]
116483753  NOTUM; palmitoleoyl-protein carboxylesterase NOTUM [KO:K19882] [EC:3.1.1.98]
116483790  RAC3; ras-related C3 botulinum toxin substrate 3 [KO:K07861]
116483814  PPP3CA; protein phosphatase 3 catalytic subunit alpha isoform X1 [KO:K04348] [EC:3.1.3.16]
116483925  APC2; adenomatous polyposis coli protein 2 isoform X1 [KO:K02085]
116483969  PRKCA; protein kinase C alpha type [KO:K02677] [EC:2.7.11.13]
116484619  NFATC4; nuclear factor of activated T-cells, cytoplasmic 4 isoform X2 [KO:K17334]
116484634  CCDC88C; protein Daple isoform X1 [KO:K25811]
116484640  DAAM1; disheveled-associated activator of morphogenesis 1 isoform X1 [KO:K04512]
116484654  PSEN1; presenilin-1 [KO:K04505] [EC:3.4.23.-]
116484796  BTRC; F-box/WD repeat-containing protein 1A isoform X1 [KO:K03362]
116484890  LZTS2; leucine zipper putative tumor suppressor 2 [KO:K26471]
116485066  WNT8B; protein Wnt-8b [KO:K00714]
116485098  CHD8; chromodomain-helicase-DNA-binding protein 8 isoform X2 [KO:K04494] [EC:5.6.2.-]
116809507  [KO:K04507]
116810281  WNT10A; protein Wnt-10a [KO:K01357]
116810282  WNT6; protein Wnt-6 isoform X1 [KO:K00445]
116810383  FZD5; frizzled-5 [KO:K02375]
116810440  FZD7; frizzled-7 [KO:K02432]
116810562  [KO:K04507]
116810576  FRZB; secreted frizzled-related protein 3 [KO:K25481]
116810870  RAC1; ras-related C3 botulinum toxin substrate 1 [KO:K04392]
116811026  [KO:K04506] [EC:2.3.2.27]
116811655  [KO:K00181] [EC:2.3.1.250]
116811684  PRICKLE3; prickle planar cell polarity protein 3 [KO:K04511]
116811758  FZD9; frizzled-9 [KO:K02842]
116812048  GPC4; glypican-4 [KO:K08110]
116812257  TBL1X; F-box-like/WD repeat-containing protein TBL1X [KO:K04508]
116812488  CAMK2B; calcium/calmodulin-dependent protein kinase type II subunit beta isoform X1 [KO:K04515] [EC:2.7.11.17]
116812540  SFRP4; secreted frizzled-related protein 4 [KO:K02185]
116812776  DVL1; segment polarity protein dishevelled homolog DVL-1 isoform X1 [KO:K02353]
116812892  CTNNBIP1; beta-catenin-interacting protein 1 isoform X1 [KO:K04493]
116813045  WNT4; protein Wnt-4 [KO:K00408]
116813290  SOX17; transcription factor SOX-17 [KO:K04495]
116813496  FZD6; frizzled-6 isoform X1 [KO:K02376]
116813517  RSPO2; R-spondin-2 [KO:K23097]
116813588  MYC; myc proto-oncogene protein [KO:K04377]
116813605  CCN4; CCN family member 4 [KO:K22471]
116814122  FZD1; frizzled-1 [KO:K02432]
116814280  WNT2; protein Wnt-2 [KO:K00182]
116814291  WNT16; protein Wnt-16 isoform X1 [KO:K01558]
116814485  CUL1; cullin-1 [KO:K03347]
131381342  TLE2; transducin-like enhancer protein 2 [KO:K04497]
Compound
C00076  Calcium cation
Reference
  Authors
Hatsell S, Rowlands T, Hiremath M, Cowin P.
  Title
Beta-catenin and Tcfs in mammary development and cancer.
  Journal
J Mammary Gland Biol Neoplasia 8:145-58 (2003)
DOI:10.1023/A:1025944723047
Reference
  Authors
Yang Y.
  Title
Wnts and wing: Wnt signaling in vertebrate limb development and musculoskeletal morphogenesis.
  Journal
Birth Defects Res Part C Embryo Today 69:305-17 (2003)
DOI:10.1002/bdrc.10026
Reference
  Authors
Kalderon D.
  Title
Similarities between the Hedgehog and Wnt signaling pathways.
  Journal
Trends Cell Biol 12:523-31 (2002)
DOI:10.1016/S0962-8924(02)02388-7
Reference
  Authors
Nusse R.
  Title
Wnts and Hedgehogs: lipid-modified proteins and similarities in signaling mechanisms at the cell surface.
  Journal
Development 130:5297-305 (2003)
DOI:10.1242/dev.00821
Reference
  Authors
Jope RS, Johnson GV.
  Title
The glamour and gloom of glycogen synthase kinase-3.
  Journal
Trends Biochem Sci 29:95-102 (2004)
DOI:10.1016/j.tibs.2003.12.004
Reference
  Authors
Veeman MT, Axelrod JD, Moon RT.
  Title
A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling.
  Journal
Dev Cell 5:367-77 (2003)
DOI:10.1016/S1534-5807(03)00266-1
Reference
  Authors
Sun TQ, Lu B, Feng JJ, Reinhard C, Jan YN, Fantl WJ, Williams LT.
  Title
PAR-1 is a Dishevelled-associated kinase and a positive regulator of Wnt signalling.
  Journal
Nat Cell Biol 3:628-36 (2001)
DOI:10.1038/35083016
Reference
  Authors
Saito-Diaz K, Chen TW, Wang X, Thorne CA, Wallace HA, Page-McCaw A, Lee E
  Title
The way Wnt works: Components and mechanism.
  Journal
Growth Factors 31:1-31 (2013)
DOI:10.3109/08977194.2012.752737
Reference
  Authors
Carethers JM
  Title
Intersection of transforming growth factor-beta and Wnt signaling pathways in colorectal cancer and metastasis.
  Journal
Gastroenterology 137:33-6 (2009)
DOI:10.1053/j.gastro.2009.05.011
Reference
  Authors
Lin Z, Gao C, Ning Y, He X, Wu W, Chen YG
  Title
The pseudoreceptor BMP and activin membrane-bound inhibitor positively modulates Wnt/beta-catenin signaling.
  Journal
J Biol Chem 283:33053-8 (2008)
DOI:10.1074/jbc.M804039200
Reference
  Authors
Niehrs C
  Title
The complex world of WNT receptor signalling.
  Journal
Nat Rev Mol Cell Biol 13:767-79 (2012)
DOI:10.1038/nrm3470
Reference
  Authors
Abou Ziki MD, Mani A
  Title
Wnt signaling, a novel pathway regulating blood pressure? State of the art review.
  Journal
Atherosclerosis 262:171-178 (2017)
DOI:10.1016/j.atherosclerosis.2017.05.001
Reference
  Authors
He Y, Ki H, Kim H, Kim K
  Title
delta-Catenin interacts with LEF-1 and negatively regulates its transcriptional activity.
  Journal
Cell Biol Int 39:954-61 (2015)
DOI:10.1002/cbin.10465
Reference
  Authors
Esaki N, Enomoto A, Takagishi M, Mizutani Y, Iida T, Ushida K, Shiraki Y, Mii S, Takahashi M
  Title
The Daple-CK1epsilon complex regulates Dvl2 phosphorylation and canonical Wnt signaling.
  Journal
Biochem Biophys Res Commun 532:406-413 (2020)
DOI:10.1016/j.bbrc.2020.08.066
Reference
  Authors
Yiew NKH, Chatterjee TK, Tang YL, Pellenberg R, Stansfield BK, Bagi Z, Fulton DJ, Stepp DW, Chen W, Patel V, Kamath VM, Litwin SE, Hui DY, Rudich SM, Kim HW, Weintraub NL
  Title
A novel role for the Wnt inhibitor APCDD1 in adipocyte differentiation: Implications for diet-induced obesity.
  Journal
J Biol Chem 292:6312-6324 (2017)
DOI:10.1074/jbc.M116.758078
Related
pathway
hmh04010  MAPK signaling pathway
hmh04110  Cell cycle
hmh04115  p53 signaling pathway
hmh04120  Ubiquitin mediated proteolysis
hmh04350  TGF-beta signaling pathway
hmh04510  Focal adhesion
hmh04520  Adherens junction
hmh05010  Alzheimer disease
KO pathway
ko04310   

DBGET integrated database retrieval system